+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Autocrine activation of the tyrosine kinase associated with the bombesin receptor in small cell lung carcinoma

Autocrine activation of the tyrosine kinase associated with the bombesin receptor in small cell lung carcinoma

Journal Of Cellular Biochemistry Supplementrt A: 103

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 027899678

Download citation: RISBibTeXText

Related references

Activation of the protein-tyrosine kinase associated with the bombesin receptor complex in small cell lung carcinomas. Proceedings of the National Academy of Sciences of the United States of America 85(7): 2166-2170, 1988

A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. Biochemical & Biophysical Research Communications 156(3): 1383-1389, 1988

Deregulation of the tyrosine kinase associated with the bombesin receptor in small cell lung carcinomas. European Journal of Cancer and Clinical Oncology 23(11): 1752, 1987

Increased attachment of small cell lung carcinoma to TNF-alpha stimulated endothelium is mediated by E-selectin and activation of endothelial cell protein kinase C and tyrosine kinase pathways. Journal of Investigative Medicine 44(7): 373A, 1996

Apoptotic sensitization in non-small cell lung cancer cells through tyrosine kinase inhibition Possible role for cytokine signaling and non-receptor tyrosine kinases as regulators of caspase activation and NSCLC cell survival. Proceedings of the American Association for Cancer Research Annual Meeting 42: 131, 2001

Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor. Thoracic Cancer 6(6): 800-804, 2015

Inhibitors of bombesin-stimulated intracellular signals: interruption of an autocrine pathway as a therapeutic strategy in small cell lung carcinoma. Progress in Clinical and Biological Research 354a: 193-207, 1990

Interstitial lung disease associated with epidermal growth factor receptor tyrosine kinase inhibitor therapy in non-small-cell lung carcinoma. Clinical Lung Cancer 8(Suppl. 1): S31-S35, 2006

Nicotine effects on proliferation and the bombesin-like peptide autocrine system in human small cell lung carcinoma SHP77 cells in culture. Lung Cancer 29(1): 1-10, 2000

Evidence for autocrine activation of a tyrosine kinase in a human gastric carcinoma cell line. Journal of Cellular Biochemistry 38(4): 229-236, 1988

Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Cancer Research and Treatment 45(2): 79-85, 2013

4 tyrosine bombesin stimulated phospholipase c activity in a membrane fraction from fibroblasts and small cell lung carcinoma cells. Clinical Research 37(2): 470A, 1989

Investigation of neurotrophic tyrosine kinase receptor 1 fusions and neurotrophic tyrosine kinase receptor family expression in non-small-cell lung cancer and sensitivity to AZD7451 in vitro. Molecular and Clinical Oncology 2(5): 725-730, 2014

Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: an analytical database. Journal of Thoracic Oncology 3(8): 832-839, 2008

Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells. Cancer Letters 162(1): 87-95, 2001